'Targeted therapies' presentation slideshows

Clinical Considerations in Evidence-based Management of GIST

Clinical Considerations in Evidence-based Management of GIST. Program Goals. GIST Current Treatment Paradigm. What is GIST?. What Causes GIST?. GIST: Treatment. Polling Question #1. Imatinib: Clinical Trial Results. Imatinib: Early Stage GIST. Resistance to Imatinib. Sunitinib .

774 views • 51 slides

An Overview of the NCI SBIR Program

577 views • 43 slides

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer. Targeted Therapies Used in the Treatment of Patients With mCRC. Case 1: 70-year-old Man With Inoperable mCRC (cont). Ziv-aflibercept: Potential Side Effects. Ziv-aflibercept: Monitoring for Side Effects.

857 views • 32 slides

Pharmacology of Oral Mucositis

567 views • 26 slides

Translational Research

489 views • 23 slides

The Promise of Personalized Medicine A Breast Cancer Survivor Perspective Mary Lou Smith, JD

385 views • 21 slides

Molecular & Genomic Pathology in the Management of Cancer: Teaching...Who, When, What and How

Molecular & Genomic Pathology in the Management of Cancer: Teaching...Who, When, What and How. Antonia R. Sepulveda MD., PhD Columbia University, NY, NY. Notice of Faculty Disclosure.

421 views • 18 slides

Dr. Rajen Tankshali Cancer Doctor

We serve growth patients and give scholarly and clinical preparing to future doctors and researchers. Our Doctors concentrate on understanding growth from its beginnings to make more secure, more powerful medicines. Analysts likewise concentrate on how qualities capacity to search for approaches to avoid or even switch hereditary changes that cause tumor. Our group of specialists and human services experts cooperate to give empathetic, condition of-the-workmanship care.

231 views • 13 slides

R&I: Ovarian Cancer Therapeutics in Major Developed Markets

The current developmental pipeline addresses these gaps in the market, with five of the 10 late stage pipeline molecules indicated as maintenance therapies, and three of the 10 indicated in platinum-resistant disease. Detailed report at: http://www.reportsandintelligence.com/ovarian-cancer-therapeutics-in-major-developed-to-2020-late-stage-pipeline-focuses-on-improved-progression-free-surival-and-targeted-therapies-market

295 views • 10 slides

Vascular Endothelial Growth Factor Antibodies Market Growth – Key Futuristic Trends and Competitive Landscape 2026

Vascular Endothelial Growth Factor (VEGF) Antibodies Market report categorizes global market by drug (Avastin, Cometriq, Eylea, Jetrea, Cyramza, Macugen, Lucentis, and Others), by route of administration (Oral, Intravenous, and Intravitreal), by application (Cancer, Ophthalmology, and Others), by distribution channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by region

110 views • 8 slides

Targeted Cancer Therapies Market By Type, and Application - Global Industry Insights, Trends, Outlook, and Opportunity A

Targeted cancer therapies differ in several ways from standard chemotherapy.

93 views • 8 slides

Breast Cancer Treatments

Breast Cancer Treatments. Types of Treatment. Surgery Radiation Chemotherapy Hormonal Therapies Targeted Therapies. Surgery. Two types Lumpectomy Removal of only tumor and possible surrounding tissue Also known as breast-conserving surgery Mastectomy

278 views • 7 slides

Breast Cancer Therapeutics Market Size expected to witness growth to surpass USD 16 billion by 2023.

Breast Cancer Therapeutics Market size was valued at over USD 7.5 billion in 2015 and is expected to witness growth to surpass USD 16 billion by 2023.

165 views • 6 slides

Non-Small Cell Lung Cancer Therapeutics Market Analysis to 2021

Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options.

216 views • 5 slides

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets Research Report 2023

Non-Small Cell Lung Cancer Therapeutics Market Report visualize the composition of the NSCLC market in terms of dominant therapies for each patient subset along with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market. For more detail click the Official URL below http://www.marketresearchhub.com/report/non-small-cell-lung-cancer-therapeutics-in-asia-pacific-markets-report.html

100 views • 5 slides